CN1150018C - Medicine for treating tachy-arrhythmia - Google Patents
Medicine for treating tachy-arrhythmia Download PDFInfo
- Publication number
- CN1150018C CN1150018C CNB011064374A CN01106437A CN1150018C CN 1150018 C CN1150018 C CN 1150018C CN B011064374 A CNB011064374 A CN B011064374A CN 01106437 A CN01106437 A CN 01106437A CN 1150018 C CN1150018 C CN 1150018C
- Authority
- CN
- China
- Prior art keywords
- root
- drug
- medicine
- arrhythmia
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a drug for treating rapid arrhythmia, which is characterized in that the drug is a medicament prepared from the following raw materials, in weight percentages, 12% to 20% of coptis (or phellodendron bark, scutellaria, oriental wormwood, radix sophorae flavescentis, ginseng, astragalus root, ophiopogon root and polygonatum), 40% to 55% of nardostachys root (or grassleaved sweetflag rhizome, pinellia tuber, american ginseng, astragalus root, schisandra and polygonatum) and 30% to 40% of crataegus fruit (or salvia root, red peony root, pueraria root, sandalwood, codonopsis root, ophiopogon root and cordyceps). Due to the adoption of the components, the drug has the advantages that clinical and animal experiments show that the drug has obvious treatment effect and no toxic and side effects by long-term taking; the drug has simple prescriptions, adopts the compound prescriptions in pairs and has wide raw material sources; and the drug has treatment effect on arrhythmia caused by social factors and drugs.
Description
The present invention relates to a kind of Chinese medicine, relate to a kind of medicine that is used for the treatment of tachy-arrhythmia specifically.
The change of the heart rate and the rhythm and pace of moving things aroused in interest, cardiac impulse form and (or) conduction of impulse unusually all be called arrhythmia.Pilosity is born in healthy people and various heart patient, and patient such as drug intoxication, electrolyte disturbance.The lighter can be asymptomatic or only had palpitation, discomfort such as uncomfortable in chest, and weight person can cause ventricular tachycardia, chamber to be quivered and dead.At present, modern medicine is according to having or not organic heart disease, the probability that whether influences cardiac output and develop into severe arrhythmia, decision Therapeutic Principle.Obviously or with organic heart disease person, except giving the treatment of the corresponding cause of disease and inducement, also can adopt measures such as electric cardioversion, electric defibrillation, electric pace-making, catheter ablation art for frequent outbreak, symptom.Wherein Drug therapy especially is still main means to tachy-arrhythmia.The medicine of treatment tachy-arrhythmia falls into 5 types at present substantially: 1, sodium channel inhibitor; 2, B receptor blocking agent; 3, the medicine of over reach current potential time-histories; 4, calcium channel blocker; 5, other medicines.In recent years research, because being extensive use of of antiarrhythmic drug can produce gastrointestinal tract, neurological symptom appearance ventricular tachyarrhythmia new or that worsen in the therapeutic process, bradycardia, atrioventricular block, the A Si syndrome, even cause sudden death.Studies have shown that according to relevant, (cardiovascular pharmacology, People's Health Publisher published in 1998, the 469th page, Chen Xiuchen Wei Zhou chief editor) most medicines have arrhythmogenic effect, and wherein: encainide is up to 11.8%-37%, flecainide 4%-33%, amiodarone 3.9%-40%, disopyramide 1%-6%, tocainide 0%-8%, propafenone 4.9-8% or the like.
Solution of the present invention is based on China's medical science to the card marquis of tachy-arrhythmia and the understanding and the Therapeutic Principle of aspects such as the cause of disease, pathogenesis thereof, and the tame unique theory that proposes " control the heart and do not terminate in the heart; it is dirty to control the heart to nurse one's health him " from traditional Chinese medical science organic conception of modern doctor, achieve with reference to modern pharmacological research, from motherland's medicine treasure-house, filter out the homologous natural edible animals and plants of medicated diet, the medicine of developing according to the theory of Chinese medical science prescription that is used for the treatment of tachy-arrhythmia.
Medicine of the present invention is to be made by the raw material of following weight percentage range:
Rhizoma Coptidis (or Cortex Phellodendri, Radix Scutellariae, Herba Artemisiae Scopariae, Radix Sophorae Flavescentis, Radix Ginseng, the Radix Astragali, Radix Ophiopogonis, Rhizoma Polygonati Odorati) 12%-20%;
Radix Et Rhizoma Nardostachyos (or Rhizoma Acori Graminei, the Rhizoma Pinelliae, Radix Panacis Quinquefolii, the Radix Astragali, Fructus Schisandrae Chinensis, Rhizoma Polygonati Odorati) 40%-55%;
Fructus Crataegi (or Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Radix Puerariae, Lignum Santali Albi, Radix Codonopsis, Radix Ophiopogonis, Rhizoma Polygonati, Cordyceps) 30-40%.
Medicine of the present invention can be made by following materials by weight percentage:
Rhizoma Coptidis 12%; Radix Et Rhizoma Nardostachyos 48%; Fructus Crataegi 40%.
Medicine of the present invention also can be made by following materials by weight percentage:
Rhizoma Coptidis 15%; Radix Et Rhizoma Nardostachyos 49%; Fructus Crataegi 36%.
Medicine of the present invention also can be made by following materials by weight percentage:
Rhizoma Coptidis 20%; Radix Et Rhizoma Nardostachyos 45%; Fructus Crataegi 35%.
Advantage of the present invention just is: 1, through clinical and zoopery, determined curative effect is taken for a long time and is had no side effect; 2, prescription is simple, adopts sisters to big compound recipe, and raw material sources are extensive; 3, to social factor institute proarrhythmia, and drug-induced arrhythmia is all effective in cure.
The present invention describes in further detail below in conjunction with specific embodiment:
Embodiment 1:
Medicine of the present invention can be made by following materials by weight percentage:
Rhizoma Coptidis 12%; Radix Et Rhizoma Nardostachyos 48%; Fructus Crataegi 40%.
The making of medicine of the present invention can be made by the Pharmacopoeia of the People's Republic of China (version appendix 1L " pharmacy of Chinese materia medica " P227-P231 page or leaf in 2000, Science and Technology of Shanghai publishing house, in October, 1993), and concrete steps are as follows:
1, Rhizoma Coptidis (half amount) being beaten powder crosses 100 mesh sieves and gets powder;
2, remainder added Fructus Crataegi and partly measures Rhizoma Coptidis extraction fluid extract in addition after Radix Et Rhizoma Nardostachyos extracted volatile oil;
3, fluid extract is adopted the low-temperature reduced-pressure drying;
4, above-mentioned fluid extract was pulverized behind 100 mesh sieves and mixed with Rhizoma Coptidis powder in the 1st step;
5, with the cryospray method Radix et Rhizoma Nardostachyos volatile oil is sprayed onto encapsulated the getting final product in mixing back in the above-mentioned fine powder.
Embodiment 2:
Medicine of the present invention also can be made by following materials by weight percentage:
Rhizoma Coptidis 20%; Radix Et Rhizoma Nardostachyos 45%; Fructus Crataegi 35%.
Manufacture method is the same.
Embodiment 3:
Medicine of the present invention also can be made by following materials by weight percentage:
Rhizoma Coptidis 15%; Radix Et Rhizoma Nardostachyos 49%; Fructus Crataegi 36%.
Manufacture method is the same.
Claims (4)
1, a kind of medicine that is used for the treatment of quick arrhythmia is characterized in that: it is to be made by the medicine of following percentage by weight: Rhizoma Coptidis 12%--20%; Radix Et Rhizoma Nardostachyos 40%--55%; Fructus Crataegi 30%--40%.
2, the medicine that is used for the treatment of quick arrhythmia according to claim 1 is characterized in that: it is to be made by the medicine of following percentage by weight: Rhizoma Coptidis 12%; Radix Et Rhizoma Nardostachyos 48%; Fructus Crataegi 40%.
3, the medicine that is used for the treatment of quick arrhythmia according to claim 1 is characterized in that: it is to be made by the medicine of following percentage by weight: Rhizoma Coptidis 15%; Radix Et Rhizoma Nardostachyos 49%; Fructus Crataegi 36%.
4, the medicine that is used for the treatment of quick arrhythmia according to claim 1 is characterized in that: it is to be made by the medicine of following percentage by weight: Rhizoma Coptidis 20%; Radix Et Rhizoma Nardostachyos 45%; Fructus Crataegi 35%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011064374A CN1150018C (en) | 2001-01-16 | 2001-01-16 | Medicine for treating tachy-arrhythmia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011064374A CN1150018C (en) | 2001-01-16 | 2001-01-16 | Medicine for treating tachy-arrhythmia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1319412A CN1319412A (en) | 2001-10-31 |
| CN1150018C true CN1150018C (en) | 2004-05-19 |
Family
ID=4655450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011064374A Expired - Lifetime CN1150018C (en) | 2001-01-16 | 2001-01-16 | Medicine for treating tachy-arrhythmia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1150018C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102742833A (en) * | 2011-04-18 | 2012-10-24 | 北京天植百桂生物技术有限公司 | Dietetic therapy product for protecting heart and preparation method thereof |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100348233C (en) * | 2005-11-09 | 2007-11-14 | 中国科学院长春应用化学研究所 | Preparation method of Chinese medicinal composition for treating allodromy |
| CN101279045B (en) * | 2007-07-12 | 2011-07-20 | 武汉市新洲区人民医院 | Medicament for curing arrhythmia and method of preparing the same |
| CN101406671B (en) * | 2008-11-12 | 2010-12-15 | 宋丽丽 | Chinese medicament preparation for treating cardiac extra systole |
| CN101837092B (en) * | 2010-04-09 | 2011-09-21 | 蔡纪强 | Chinese medicament for curing cardiopathy |
| CN103181562B (en) * | 2011-12-31 | 2015-08-12 | 谢鸣 | A kind of have health food of Summertime health-care effect and preparation method thereof |
| CN102836320B (en) * | 2012-10-08 | 2013-09-04 | 河南中医学院 | Chinese medicinal pill for treating tachyarrhythmia |
| CN104825796A (en) * | 2014-01-17 | 2015-08-12 | 刘镜 | Preparation method of traditional Chinese medicine for treating arrhythmia |
| CN103893346B (en) * | 2014-04-30 | 2015-09-30 | 陈玉贵 | One treats ARR Chinese medicine of motive asthenia type and preparation method thereof |
| CN104208419A (en) * | 2014-08-29 | 2014-12-17 | 王刚 | Traditional Chinese medicine oral liquid for treating arrhythmia |
| CN106138795B (en) * | 2015-04-21 | 2020-07-31 | 王玉梅 | Traditional Chinese medicine composition for treating premature beat and preparation method thereof |
| CN105748771A (en) * | 2016-03-14 | 2016-07-13 | 福建中医药大学 | Pharmaceutical composition for preventing and treating myocardial ischemia and preparation method thereof |
| CN113679781B (en) * | 2021-09-26 | 2022-07-01 | 山东第一医科大学附属省立医院(山东省立医院) | Traditional Chinese medicine composition for treating tachyarrhythmia and preparation method and application thereof |
-
2001
- 2001-01-16 CN CNB011064374A patent/CN1150018C/en not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102742833A (en) * | 2011-04-18 | 2012-10-24 | 北京天植百桂生物技术有限公司 | Dietetic therapy product for protecting heart and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1319412A (en) | 2001-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101181600B (en) | Traditional Chinese medicine composition for curing cardiovascular and cerebrovascular diseases | |
| CN1334121A (en) | Medicinal composition for restoring cardiac collaterals and its application | |
| CN1224614A (en) | Medicine for preventing and curing cardiac and cerebral vascular diseases and its preparation | |
| CN1305844A (en) | Medicine for treating congestive heart failure | |
| CN1150018C (en) | Medicine for treating tachy-arrhythmia | |
| CN1150928C (en) | Medicine for curing cancers and its preparation method | |
| CN1931329A (en) | Stomatocase treating medicine | |
| CN101953918A (en) | Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases | |
| CN1242201A (en) | Patent traditional Chinese medicine for treating psoriasis, and method for preparing same | |
| CN1077896A (en) | Medicine for psoriasis and manufacture method | |
| CN104225507A (en) | Chinese medicine for treating limb paralysis and pain caused by cerebral hemorrhage | |
| CN1365822A (en) | 'Shugan Lidan' capsule and its preparing process | |
| CN1399999A (en) | Medicine for curing malignant turnor and its preparation method | |
| CN1101199C (en) | Chinese-medicinal capsule for treating hyperlipomia | |
| CN1060379C (en) | Chines medicine for treating vitiligo and preparation method thereof | |
| CN1127344C (en) | Oral pill for curing diabetes and its complication | |
| CN1164294C (en) | Liver cancer resisting medicine | |
| CN1141138C (en) | Medicine composition for curing coronary heart disease | |
| CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN1263479C (en) | Chinese traditional medicine for treating cardiopathy | |
| CN1204908C (en) | Deafness and tinnitus treating Chinese medicine and its prepn | |
| CN1136896C (en) | Live-nourishing 'yanggan' pill | |
| CN1036503C (en) | Medicine for treating systemic lupus erythematosus and producing method thereof | |
| CN1411860A (en) | Tianqi sugar-reducing capsule | |
| CN1316989C (en) | Capsule with dried human placemta and red sage root and its preparing process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term |
Granted publication date: 20040519 |
|
| CX01 | Expiry of patent term |